Pharmacologic and radiotherapeutic interventions for advanced pancreatic cancer
- 24 June 2013
- journal article
- research article
- Published by Wiley in Cochrane Database of Systematic Reviews
- No. 6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Second-line therapy for advanced pancreatic cancer: A review of the literature and future directionsCancer Treatment Reviews, 2009
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic CancerJournal of Clinical Oncology, 2009
- Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus StatementAnnals of Surgical Oncology, 2009
- Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancerBMC Cancer, 2008
- Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic CancerJournal of Clinical Oncology, 2007
- Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer RegistryGut, 2005
- Long-Term Survival After Curative Resection for Pancreatic Ductal AdenocarcinomaAnnals of Surgery, 1996
- Pancreatic CarcinomaNew England Journal of Medicine, 1992
- Cancer of the pancreasCurrent Problems in Cancer, 1977